ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Anabolics Can Affect Oral Health
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 190881" data-attributes="member: 13851"><p><strong>Periodontal clinical status, microbial profile, and expression of interleukin-1β in men under androgenic anabolic steroids abuse </strong></p><p><span style="color: rgb(44, 130, 201)">Stephanie von Stein Cubas Warnavin & Henrique Meister Valenga & Thainá Biudes Conforto Costa & Joao Daniel Paganella Chaves & Luis Carlos Spolidorio & Denise Madalena Palomari Spolidorio & Magda Feres & Geisla Mary Silva Soares & Joao Paulo Steffens </span></p><p></p><p></p><p></p><p></p><p><strong>Abstract </strong></p><p><strong></strong></p><p><strong>Objectives </strong><em><span style="color: rgb(184, 49, 47)">Androgenic anabolic steroids (AAS) abuse is a serious health problem associated with several systemic complications.</span></em> <span style="color: rgb(44, 130, 201)"><em>Here, we evaluated the periodontal clinical status, microbial profile, and expression of total protein (TP) and interleukin (IL)-1β in men using AAS. </em></span></p><p></p><p><strong>Materials and methods</strong> Men using AAS were recruited (case group) and matched for age with men who had never used AAS (control group) but also performed physical activities. Plaque index (PI), marginal bleeding (MB), probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BoP) were evaluated. Crevicular fluid and subgingival biofilm were collected from healthy and diseased sites (PD ≥ 4 mm with CAL ≥ 1 mm and BoP) and evaluated for TP, IL-1β, and proportions of 40 bacterial species.</p><p></p><p><strong>Results </strong>Thirty patients were included (n = 15/group). AAS consumers had significantly higher mean PD and a higher percentage of diseased sites; sites with PD ≥ 4 mm or with CAL ≥ 1 mm than non-consumers. Also, AAS users showed a more dysbiotic biofilm containing lower proportions of host-compatible species and higher proportions of pathogens. IL-1β expression was statistically higher in diseased than in healthy sites only in the control group. A statistically positive correlation was detected between periodontal pathogens and IL-1β expression. The number of AAS cycles was positively associated with higher percentages of periodontal pathogens, but not with IL-1β or total protein concentrations.</p><p></p><p><strong>Conclusions</strong> <em><span style="color: rgb(184, 49, 47)">AAS intake can worsen clinical and immunological periodontal conditions and the biofilm composition in healthy sites. </span></em></p><p></p><p></p><p></p><p></p><p></p><p><strong>Introduction </strong></p><p></p><p><em><span style="color: rgb(184, 49, 47)">Testosterone is the main male sex hormone responsible for the development of primary and secondary adult sexual characteristics (e.g., muscle mass, facial hair, libido, and sperm production) and, to a lesser extent, water, and electrolyte balance [1, 2].</span></em> <span style="color: rgb(44, 130, 201)"><em>Synthetic steroids derived from testosterone, such as androgenic anabolic steroids (AAS) have been developed to treat men suffering from hypogonadism, late puberty, and some types of impotence [3, 4]. However, these products started to be widely used by professional or recreational athletes aiming to increase performance, gain lean muscle mass, and decrease body fat percentage [5].</em></span> <span style="color: rgb(184, 49, 47)"><em>The use of AAS in high doses by athletes and bodybuilders may lead to a variety of side effects, which include fluid retention, acne, hepatic intoxication, arterial hypertension, blood cell disorders, anemia, depression, infertility, and even heart-related conditions [6].</em></span> <em><span style="color: rgb(44, 130, 201)">The adverse effects of inappropriate and abusive use of AAS vary according to the individual's age and sex, as well as the dose, duration, and type of steroid. The protocol of use of AAS (e.g., dose, duration, and the interval between courses) varies according to the aim of the treatment and is frequently called AAS cycle [3]. </span></em></p><p></p><p><span style="color: rgb(184, 49, 47)"><em>It has been suggested that steroid hormones may influence the physiology of oral and periodontal tissues due to the homeostasis of anabolic and catabolic functions in the connective tissue and bone matrix [7]. These hormones and their derivatives may play a role in the progression of periodontal disease, including alterations in the composition of the microbiota and the healing process [8–13].</em></span><span style="color: rgb(44, 130, 201)"><em> The periodontal biofilm is a complex structure that may change according to the host immune competence and the environmental conditions [14]. Environmental changes can generate a shift in microbiological profile by increasing microorganisms associated with the onset and progression of periodontitis (red and orange microbial complexes) and decreasing those associated with periodontal health (purple, yellow, green, and Actinomyces complexes) [15–17]. </em></span></p><p></p><p><span style="color: rgb(184, 49, 47)"><em>In humans, the use of AAS has been associated with gingival enlargement [18], higher prevalence of severe periodontitis, greater gingival inflammation, and an increased odds ratio to be infected with Prevotella intermedia, Aggregatibacter actinomycetemcomitans, and Candida spp. than non-AAS users [13].</em></span> <span style="color: rgb(44, 130, 201)"><em>Similarly, high endogenous testosterone levels were correlated with higher prevalence and severity of periodontitis in men [19]. </em></span><em><span style="color: rgb(44, 130, 201)">In animals, treatment with supraphysiological doses of testosterone has been shown to increase ligature-induced bone loss in orchiectomized male rats [20]. In vitro, it was demonstrated that high doses of testosterone increased osteoclasteogenesis directly from RAW264.7 cells, in addition to increasing RANKL/OPG ratio in murine osteoblast primary culture [20, 21]. </span></em><span style="color: rgb(184, 49, 47)"><em><strong>However, to the best of our knowledge, a combined evaluation of the microbiological and immunological oral response to AAS has not been performed in humans. Among immunological features, interleukin (IL)-1β is one of the most common biomarkers that can be used as an indicator of periodontal disease progression [22]. </strong></em></span></p><p></p><p><strong><span style="color: rgb(184, 49, 47)"><em>Hence, the aim of this study was to evaluate if AAS influences periodontal clinical and microbiological parameters, as well as to assess the expression of total protein and interleukin (IL)-1β in the gingival crevicular fluid. </em></span></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong><span style="color: rgb(44, 130, 201)"><em>In conclusion, the results of this study indicate that AAS intake can negatively impact periodontal health, suggesting that dental care professionals should perform full-mouth periodontal screening and schedule regular follow-up appointments for patients under AAS use. </em></span></strong></p></blockquote><p></p>
[QUOTE="madman, post: 190881, member: 13851"] [B]Periodontal clinical status, microbial profile, and expression of interleukin-1β in men under androgenic anabolic steroids abuse [/B] [COLOR=rgb(44, 130, 201)]Stephanie von Stein Cubas Warnavin & Henrique Meister Valenga & Thainá Biudes Conforto Costa & Joao Daniel Paganella Chaves & Luis Carlos Spolidorio & Denise Madalena Palomari Spolidorio & Magda Feres & Geisla Mary Silva Soares & Joao Paulo Steffens [/COLOR] [B]Abstract Objectives [/B][I][COLOR=rgb(184, 49, 47)]Androgenic anabolic steroids (AAS) abuse is a serious health problem associated with several systemic complications.[/COLOR][/I] [COLOR=rgb(44, 130, 201)][I]Here, we evaluated the periodontal clinical status, microbial profile, and expression of total protein (TP) and interleukin (IL)-1β in men using AAS. [/I][/COLOR] [B]Materials and methods[/B] Men using AAS were recruited (case group) and matched for age with men who had never used AAS (control group) but also performed physical activities. Plaque index (PI), marginal bleeding (MB), probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BoP) were evaluated. Crevicular fluid and subgingival biofilm were collected from healthy and diseased sites (PD ≥ 4 mm with CAL ≥ 1 mm and BoP) and evaluated for TP, IL-1β, and proportions of 40 bacterial species. [B]Results [/B]Thirty patients were included (n = 15/group). AAS consumers had significantly higher mean PD and a higher percentage of diseased sites; sites with PD ≥ 4 mm or with CAL ≥ 1 mm than non-consumers. Also, AAS users showed a more dysbiotic biofilm containing lower proportions of host-compatible species and higher proportions of pathogens. IL-1β expression was statistically higher in diseased than in healthy sites only in the control group. A statistically positive correlation was detected between periodontal pathogens and IL-1β expression. The number of AAS cycles was positively associated with higher percentages of periodontal pathogens, but not with IL-1β or total protein concentrations. [B]Conclusions[/B] [I][COLOR=rgb(184, 49, 47)]AAS intake can worsen clinical and immunological periodontal conditions and the biofilm composition in healthy sites. [/COLOR][/I] [B]Introduction [/B] [I][COLOR=rgb(184, 49, 47)]Testosterone is the main male sex hormone responsible for the development of primary and secondary adult sexual characteristics (e.g., muscle mass, facial hair, libido, and sperm production) and, to a lesser extent, water, and electrolyte balance [1, 2].[/COLOR][/I] [COLOR=rgb(44, 130, 201)][I]Synthetic steroids derived from testosterone, such as androgenic anabolic steroids (AAS) have been developed to treat men suffering from hypogonadism, late puberty, and some types of impotence [3, 4]. However, these products started to be widely used by professional or recreational athletes aiming to increase performance, gain lean muscle mass, and decrease body fat percentage [5].[/I][/COLOR] [COLOR=rgb(184, 49, 47)][I]The use of AAS in high doses by athletes and bodybuilders may lead to a variety of side effects, which include fluid retention, acne, hepatic intoxication, arterial hypertension, blood cell disorders, anemia, depression, infertility, and even heart-related conditions [6].[/I][/COLOR] [I][COLOR=rgb(44, 130, 201)]The adverse effects of inappropriate and abusive use of AAS vary according to the individual's age and sex, as well as the dose, duration, and type of steroid. The protocol of use of AAS (e.g., dose, duration, and the interval between courses) varies according to the aim of the treatment and is frequently called AAS cycle [3]. [/COLOR][/I] [COLOR=rgb(184, 49, 47)][I]It has been suggested that steroid hormones may influence the physiology of oral and periodontal tissues due to the homeostasis of anabolic and catabolic functions in the connective tissue and bone matrix [7]. These hormones and their derivatives may play a role in the progression of periodontal disease, including alterations in the composition of the microbiota and the healing process [8–13].[/I][/COLOR][COLOR=rgb(44, 130, 201)][I] The periodontal biofilm is a complex structure that may change according to the host immune competence and the environmental conditions [14]. Environmental changes can generate a shift in microbiological profile by increasing microorganisms associated with the onset and progression of periodontitis (red and orange microbial complexes) and decreasing those associated with periodontal health (purple, yellow, green, and Actinomyces complexes) [15–17]. [/I][/COLOR] [COLOR=rgb(184, 49, 47)][I]In humans, the use of AAS has been associated with gingival enlargement [18], higher prevalence of severe periodontitis, greater gingival inflammation, and an increased odds ratio to be infected with Prevotella intermedia, Aggregatibacter actinomycetemcomitans, and Candida spp. than non-AAS users [13].[/I][/COLOR] [COLOR=rgb(44, 130, 201)][I]Similarly, high endogenous testosterone levels were correlated with higher prevalence and severity of periodontitis in men [19]. [/I][/COLOR][I][COLOR=rgb(44, 130, 201)]In animals, treatment with supraphysiological doses of testosterone has been shown to increase ligature-induced bone loss in orchiectomized male rats [20]. In vitro, it was demonstrated that high doses of testosterone increased osteoclasteogenesis directly from RAW264.7 cells, in addition to increasing RANKL/OPG ratio in murine osteoblast primary culture [20, 21]. [/COLOR][/I][COLOR=rgb(184, 49, 47)][I][B]However, to the best of our knowledge, a combined evaluation of the microbiological and immunological oral response to AAS has not been performed in humans. Among immunological features, interleukin (IL)-1β is one of the most common biomarkers that can be used as an indicator of periodontal disease progression [22]. [/B][/I][/COLOR] [B][COLOR=rgb(184, 49, 47)][I]Hence, the aim of this study was to evaluate if AAS influences periodontal clinical and microbiological parameters, as well as to assess the expression of total protein and interleukin (IL)-1β in the gingival crevicular fluid. [/I][/COLOR] [COLOR=rgb(44, 130, 201)][I]In conclusion, the results of this study indicate that AAS intake can negatively impact periodontal health, suggesting that dental care professionals should perform full-mouth periodontal screening and schedule regular follow-up appointments for patients under AAS use. [/I][/COLOR][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Anabolics Can Affect Oral Health
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top